Kalivir Immunotherapeutics, Inc.
- Biotech or pharma, therapeutic R&D
KALIVIR is a clinical-stage biopharmaceutical company dedicated to developing systemically deliverable oncolytic virus immunotherapies.
June 16-19, 2025
Boston Convention & Exhibition Center
KALIVIR is a clinical-stage biopharmaceutical company dedicated to developing systemically deliverable oncolytic virus immunotherapies.